Aerogen, the world leader in aerosol drug delivery, continues to expand its international activities with the opening of its Indian headquarters in Delhi. The office will be located in the ABW Rectangle One Building (131) in New Delhi.
Managed by Aerogen Sales Director Asia Pacific, Richard Featherstone, and supported by Country Manager India & Subcontinent, Rajiv Julka, the team will be made up to include five Clinical Specialists that will be located across India.
In the last number of years Aerogen has seen growing demand in India and across Asia. John Power, Aerogen CEO and Founder, states: “India is an extremely important market for Aerogen, and we look forward to strengthening our commitment here with a location in New Delhi. With a local office and local team we can now work more closely with our customers and partners to meet their individual needs and grow together.”
The announcement was made in the presence of Irish Ambassador to India, Brian McElduff and Enterprise Ireland Director of India & South Asia, David Flood.
For further information please contact firstname.lastname@example.org or
Aerogen India Ltd.
131, ABW Rectangle One Building,
D-4, Saket District Centre, Saket,
New Delhi 110017.
Phone +91 11 41422577
Aerogen is the world’s leading medical device company specialising in the design, manufacture and commercialisation of aerosol drug delivery systems. Aerogen’s patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of critically ill patients of all ages.
Employing almost 200 experienced staff worldwide, Aerogen has a strong international presence with offices in Ireland, the UK, France, Germany, China, the United States, India and The Middle East. Over seven million patients have benefitted from Aerogen technology.